Question

The author argues that the Food and Drug Administration must modernize its approach to ensure the safety and effectiveness of medical products in a rapidly advancing world. One strong piece of evidence used is the FDA’s acknowledgment of outdated procedures, which shows that internal recognition supports the need for change. Second, the article cites specific technological advances in medicine, such as gene therapy and personalized medicine, to demonstrate how the FDA’s traditional methods are no longer sufficient. This makes the claim urgent and relevant. Third, the blueprint outlines steps the FDA is taking, such as improving data systems and enhancing scientific expertise, which shows practical, actionable solutions are already underway. Each of these points supports the central claim by proving both the necessity of modernization and the FDA’s commitment to reform.
rephrase like an 8th grader

Answer 1

The author believes that the Food and Drug Administration (FDA) needs to update how it works to keep medical products safe and effective in our fast-changing world. One strong reason for this is that the FDA has admitted its old methods are outdated, which shows they recognize the need for change. The article also talks about new medical advances, like gene therapy and personalized medicine, to highlight that the FDA's traditional ways are not enough anymore. This makes the argument urgent and important. Lastly, the article mentions steps the FDA is already taking, such as improving data systems and getting better scientific knowledge, which shows they are committed to making real changes. All these points support the main idea that the FDA must modernize and is working on it.